Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma

Summary A central event in the development of malignant melanoma is the loss of the tumor‐suppressor protein E‐cadherin. Here, we report that this loss is linked to the activation of the proto‐oncogene c‐Jun, a key player in tumorigenesis. In vivo, malignant melanomas show strong expression of the c...

Full description

Saved in:
Bibliographic Details
Published in:Pigment cell and melanoma research Vol. 24; no. 1; pp. 148 - 164
Main Authors: Spangler, B., Vardimon, L., Bosserhoff, A. K., Kuphal, S.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-02-2011
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Summary A central event in the development of malignant melanoma is the loss of the tumor‐suppressor protein E‐cadherin. Here, we report that this loss is linked to the activation of the proto‐oncogene c‐Jun, a key player in tumorigenesis. In vivo, malignant melanomas show strong expression of the c‐Jun protein in contrast to melanocytes. Interestingly, c‐Jun mRNA levels did not differ in the melanoma cell lines when compared to melanocytes, suggesting that c‐Jun could be regulated at the post‐transcriptional level. To uncover the link between E‐cadherin and c‐Jun, we re‐expressed E‐cadherin in melanoma cells and detected decreased protein expression and activity of c‐Jun. Furthermore, c‐Jun accumulation is dependent on active E‐cadherin‐mediated cell–cell adhesion and regulated via the cytoskeleton. Additionally, we determined that, with respect to c‐Jun regulation, there are two melanoma subgroups. One subgroup regulates c‐Jun expression via the newly discovered E‐cadherin‐dependent signaling pathway, whereas the other subgroup uses the MAPKinases to regulate its expression. In summary, our data provide novel insights into the tumor‐suppressor function of E‐cadherin, which contributes to the suppression of c‐Jun protein translation and transcriptional activity independent of MAPKinases.
AbstractList A central event in the development of malignant melanoma is the loss of the tumor-suppressor protein E-cadherin. Here, we report that this loss is linked to the activation of the proto-oncogene c-Jun, a key player in tumorigenesis. In vivo, malignant melanomas show strong expression of the c-Jun protein in contrast to melanocytes. Interestingly, c-Jun mRNA levels did not differ in the melanoma cell lines when compared to melanocytes, suggesting that c-Jun could be regulated at the post-transcriptional level. To uncover the link between E-cadherin and c-Jun, we re-expressed E-cadherin in melanoma cells and detected decreased protein expression and activity of c-Jun. Furthermore, c-Jun accumulation is dependent on active E-cadherin-mediated cell-cell adhesion and regulated via the cytoskeleton. Additionally, we determined that, with respect to c-Jun regulation, there are two melanoma subgroups. One subgroup regulates c-Jun expression via the newly discovered E-cadherin-dependent signaling pathway, whereas the other subgroup uses the MAPKinases to regulate its expression. In summary, our data provide novel insights into the tumor-suppressor function of E-cadherin, which contributes to the suppression of c-Jun protein translation and transcriptional activity independent of MAPKinases.
Summary A central event in the development of malignant melanoma is the loss of the tumor‐suppressor protein E‐cadherin. Here, we report that this loss is linked to the activation of the proto‐oncogene c‐Jun, a key player in tumorigenesis. In vivo, malignant melanomas show strong expression of the c‐Jun protein in contrast to melanocytes. Interestingly, c‐Jun mRNA levels did not differ in the melanoma cell lines when compared to melanocytes, suggesting that c‐Jun could be regulated at the post‐transcriptional level. To uncover the link between E‐cadherin and c‐Jun, we re‐expressed E‐cadherin in melanoma cells and detected decreased protein expression and activity of c‐Jun. Furthermore, c‐Jun accumulation is dependent on active E‐cadherin‐mediated cell–cell adhesion and regulated via the cytoskeleton. Additionally, we determined that, with respect to c‐Jun regulation, there are two melanoma subgroups. One subgroup regulates c‐Jun expression via the newly discovered E‐cadherin‐dependent signaling pathway, whereas the other subgroup uses the MAPKinases to regulate its expression. In summary, our data provide novel insights into the tumor‐suppressor function of E‐cadherin, which contributes to the suppression of c‐Jun protein translation and transcriptional activity independent of MAPKinases.
Summary A central event in the development of malignant melanoma is the loss of the tumor‐suppressor protein E‐cadherin. Here, we report that this loss is linked to the activation of the proto‐oncogene c‐Jun, a key player in tumorigenesis. In vivo , malignant melanomas show strong expression of the c‐Jun protein in contrast to melanocytes. Interestingly, c‐Jun mRNA levels did not differ in the melanoma cell lines when compared to melanocytes, suggesting that c‐Jun could be regulated at the post‐transcriptional level. To uncover the link between E‐cadherin and c‐Jun, we re‐expressed E‐cadherin in melanoma cells and detected decreased protein expression and activity of c‐Jun. Furthermore, c‐Jun accumulation is dependent on active E‐cadherin‐mediated cell–cell adhesion and regulated via the cytoskeleton. Additionally, we determined that, with respect to c‐Jun regulation, there are two melanoma subgroups. One subgroup regulates c‐Jun expression via the newly discovered E‐cadherin‐dependent signaling pathway, whereas the other subgroup uses the MAPKinases to regulate its expression. In summary, our data provide novel insights into the tumor‐suppressor function of E‐cadherin, which contributes to the suppression of c‐Jun protein translation and transcriptional activity independent of MAPKinases.
Author Vardimon, L.
Spangler, B.
Bosserhoff, A. K.
Kuphal, S.
Author_xml – sequence: 1
  givenname: B.
  surname: Spangler
  fullname: Spangler, B.
  organization:  Institute of Pathology, University of Regensburg, Regensburg, Germany
– sequence: 2
  givenname: L.
  surname: Vardimon
  fullname: Vardimon, L.
  organization:  Department of Biochemistry, Tel Aviv University, Tel Aviv, Israel
– sequence: 3
  givenname: A. K.
  surname: Bosserhoff
  fullname: Bosserhoff, A. K.
  organization:  Institute of Pathology, University of Regensburg, Regensburg, Germany
– sequence: 4
  givenname: S.
  surname: Kuphal
  fullname: Kuphal, S.
  organization:  Institute of Pathology, University of Regensburg, Regensburg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20977688$$D View this record in MEDLINE/PubMed
BookMark eNqNkUuT1CAUhSlrLOehf8Fip5u0l5AEsnBhdc2Mj1HH8bmjaB5Km0ALRLv_vcQee2nJhnvhOxfqnFN05IM3CGECC1LWk_WCsLatSMO_LGoopwCMs8X2Djo5XBwdakaO0WlKa4AO2p7eQ8c19Ix1nJ8gfR1SrnKUPqnoNtkFLwcczddpkHODVfA5hmEwGq92-LxSUn8z0XnsEnbjJsQsfcY2RKyql5PHUmX30-UdLshoBunDKO-ju1YOyTy43c_Qx4vzD8vn1dXbyxfLZ1eVamjPKg7AqW1sQ-xKkx4oVRaglh1vTU9WtQXdawtW1Ro6Q3XLDZfAVW-bhskO6Bl6tJ-7ieHHZFIWo0vKDOUXJkxJ8AZoC5TQQj7-J0mg5lDcgxnle1TFkFI0VmyiG2XcFUjMaYi1mI0Ws-liTkP8SUNsi_Th7SvTajT6IPxrfwGe7oFfbjC7_x4srpevb0pV9NVe71I224Nexu-iY5S14vObS_Hpgt28X77i4h39DbJvqtc
CitedBy_id crossref_primary_10_1038_onc_2017_135
crossref_primary_10_1038_s41419_019_1821_9
crossref_primary_10_1080_15384047_2016_1156264
crossref_primary_10_1016_j_abb_2011_10_020
crossref_primary_10_1128_MCB_06619_11
crossref_primary_10_1038_celldisc_2016_28
crossref_primary_10_1002_ar_23992
crossref_primary_10_1016_j_cellsig_2021_110034
crossref_primary_10_1371_journal_pone_0119402
crossref_primary_10_1038_labinvest_2014_3
crossref_primary_10_18632_oncotarget_2426
crossref_primary_10_3390_cancers11071037
crossref_primary_10_3389_fonc_2016_00128
crossref_primary_10_1158_0008_5472_CAN_19_0040
crossref_primary_10_1083_jcb_201612125
crossref_primary_10_18632_oncotarget_26508
crossref_primary_10_1016_j_it_2016_03_009
crossref_primary_10_1038_s41418_018_0210_8
crossref_primary_10_1038_ncomms9755
crossref_primary_10_1038_onc_2012_307
crossref_primary_10_1016_j_ejcb_2013_10_003
crossref_primary_10_1073_pnas_1203659109
crossref_primary_10_1126_scisignal_aab1111
crossref_primary_10_1371_journal_pone_0089491
crossref_primary_10_1007_s12253_017_0334_z
Cites_doi 10.1038/79120
10.1016/j.molcel.2005.06.025
10.1111/j.1742-4658.2008.06349.x
10.1097/00008390-199806000-00003
10.1002/jcp.10008
10.1128/MCB.11.5.2804
10.1023/A:1015948505117
10.1038/sj.onc.1200991
10.1016/S0092-8674(00)00193-8
10.1007/BF00054016
10.1073/pnas.87.11.4246
10.1016/j.ccr.2007.03.009
10.1136/mp.50.6.289
10.1038/sj.onc.1207797
10.1016/0092-8674(95)90370-4
10.1038/nrc1209
10.1016/S1097-2765(04)00153-4
10.1002/(SICI)1097-0029(19970815)38:4<343::AID-JEMT2>3.0.CO;2-K
10.1038/371171a0
10.1002/j.1460-2075.1995.tb00301.x
10.1016/S0092-8674(05)80058-3
10.1073/pnas.91.2.609
10.4161/cc.3.2.648
10.1083/jcb.130.1.67
10.1002/mc.2940100205
10.1128/MCB.20.10.3616-3625.2000
10.1083/jcb.116.4.989
10.1038/sj.onc.1209114
10.1128/MCB.11.9.4466
10.1091/mbc.E08-12-1196
10.1038/sj.onc.1209054
10.1084/jem.20082044
10.1038/354494a0
10.1038/sj.onc.1207831
10.1038/sj.onc.1204383
10.1083/jcb.106.3.761
10.1074/jbc.270.28.16483
10.3109/15419069409014207
10.1073/pnas.85.22.8464
10.4161/cc.2.3.388
10.1128/MCB.20.2.575-582.2000
10.1126/science.2541502
10.1158/0008-5472.CAN-07-2938
10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K
10.1016/S0002-9440(10)65023-7
10.1038/32918
10.1126/science.7824938
10.1034/j.1600-0625.2003.120310.x
10.1136/mp.52.3.151
10.1016/S1534-5807(03)00161-8
10.1074/jbc.M011224200
10.1158/0008-5472.CAN-08-0041
10.1038/sj.onc.1204389
10.1038/353670a0
10.1128/MCB.25.20.9138-9150.2005
10.1038/337661a0
ContentType Journal Article
Copyright 2010 John Wiley & Sons A/S
2010 John Wiley & Sons A/S.
Copyright_xml – notice: 2010 John Wiley & Sons A/S
– notice: 2010 John Wiley & Sons A/S.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
7X8
DOI 10.1111/j.1755-148X.2010.00787.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Nucleic Acids Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Zoology
EISSN 1755-148X
EndPage 164
ExternalDocumentID 10_1111_j_1755_148X_2010_00787_x
20977688
PCMR787
ark_67375_WNG_VF7RSCK8_Q
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HGLYW
HVGLF
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WIH
WIJ
WIK
WNSPC
WOHZO
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
XG1
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TM
7X8
ID FETCH-LOGICAL-c4397-80083f4f41fbd19033cf002a685e91b2f0d9df0fc2d06e3d58e8a08c9f447a603
IEDL.DBID 33P
ISSN 1755-1471
IngestDate Fri Aug 16 21:27:55 EDT 2024
Fri Aug 16 11:58:23 EDT 2024
Fri Aug 23 01:51:38 EDT 2024
Sat Sep 28 07:58:56 EDT 2024
Sat Aug 24 00:48:49 EDT 2024
Wed Oct 30 09:55:44 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2010 John Wiley & Sons A/S.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4397-80083f4f41fbd19033cf002a685e91b2f0d9df0fc2d06e3d58e8a08c9f447a603
Notes istex:D0C7BDFD7E5E96A7D9275FDF3D928C9F5CF700B0
ark:/67375/WNG-VF7RSCK8-Q
ArticleID:PCMR787
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 20977688
PQID 1028075503
PQPubID 23462
PageCount 17
ParticipantIDs proquest_miscellaneous_840350313
proquest_miscellaneous_1028075503
crossref_primary_10_1111_j_1755_148X_2010_00787_x
pubmed_primary_20977688
wiley_primary_10_1111_j_1755_148X_2010_00787_x_PCMR787
istex_primary_ark_67375_WNG_VF7RSCK8_Q
PublicationCentury 2000
PublicationDate 2011-02
February 2011
2011-Feb
2011-02-00
20110201
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle Pigment cell and melanoma research
PublicationTitleAlternate Pigment Cell Melanoma Res
PublicationYear 2011
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Stappert, J., and Kemler, R. (1994). A short core region of E-cadherin is essential for catenin binding and is highly phosphorylated. Cell Adhes. Commun. 2, 319-327.
Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M. (1989). Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337, 661-663.
Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., and Herlyn, M. (2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515-1525.
Poser, I., Tatzel, J., Kuphal, S., and Bosserhoff, A.K. (2004). Functional role of MIA in melanocytes and early development of melanoma. Oncogene 23, 6115-6124.
Bernstein, L.R., and Colburn, N.H. (1989). AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244, 566-569.
Boukamp, P., Dzarlieva-Petrusevska, R.T., Breitkreuz, D., Hornung, J., Markham, A., and Fusenig, N.E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
Blattner, C., Kannouche, P., Litfin, M., Bender, K., Rahmsdorf, H.J., Angulo, J.F., and Herrlich, P. (2000). UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol. Cell. Biol. 20, 3616-3625.
Nobes, C.D., and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.
Sommers, C.L., Gelmann, E.P., Kemler, R., Cowin, P., and Byers, S.W. (1994). Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res. 54, 3544-3552.
Wenke, A.K., Kjellman, C., Lundgren-Akerlund, E., Uhlmann, C., Haass, N.K., Herlyn, M., and Bosserhoff, A.K. (2007). Expression of integrin alpha10 is induced in malignant melanoma. Cell. Oncol. 29, 373-386.
Berx, G., Cleton-Jansen, A.M., Nollet, F., de Leeuw, W.J., van de Vijver, M., Cornelisse, C., and van Roy, F. (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14, 6107-6115.
Onder, T.T., Gupta, P.B., Mani, S.A., Yang, J., Lander, E.S., and Weinberg, R.A. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-3654.
Silye, R., Karayiannakis, A.J., Syrigos, K.N. et al. (1998). E-cadherin/catenin complex in benign and malignant melanocytic lesions. J. Pathol. 186, 350-355.
Ozawa, M., and Kemler, R. (1992). Molecular organization of the uvomorulin-catenin complex. J. Cell Biol. 116, 989-996.
Deng, T., and Karin, M. (1994). c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371, 171-175.
Kennedy, N.J., and Davis, R.J. (2003). Role of JNK in tumor development. Cell Cycle 2, 199-201.
Xiao, L., and Lang, W. (2000). A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 60, 400-408.
Halaban, R., Kwon, B.S., Ghosh, S., Delli, B.P., and Baird, A. (1988). bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3, 177-186.
Kuphal, S., Poser, I., Jobin, C., Hellerbrand, C., and Bosserhoff, A.K. (2004). Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23, 8509-8519.
Ryder, K., and Nathans, D. (1988). Induction of protooncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA 85, 8464-8467.
Hendrix, M.J., Seftor, E.A., Chu, Y.W., Trevor, K.T., and Seftor, R.E. (1996). Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525.
Weiss, C., and Bohmann, D. (2004). Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle 3, 111-113.
Knudsen, K.A., Soler, A.P., Johnson, K.R., and Wheelock, M.J. (1995). Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J. Cell Biol. 130, 67-77.
Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
Lopez-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L.H., and Ronai, Z. (2005). RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19, 309-320.
Rimm, D.L., Sinard, J.H., and Morrow, J.S. (1995). Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab. Invest. 72, 506-512.
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A.E. (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392, 402-405.
Furukawa, F., Fujii, K., Horiguchi, Y., Matsuyoshi, N., Fujita, M., Toda, K., Imamura, S., Wakita, H., Shirahama, S., and Takigawa, M. (1997). Roles of E- and P-cadherin in the human skin. Microsc. Res. Tech. 38, 343-352.
Kolbus, A., Herr, I., Schreiber, M., Debatin, K.M., Wagner, E.F., and Angel, P. (2000). c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20, 575-582.
Massoumi, R., Kuphal, S., Hellerbrand, C., Haas, B., Wild, P., Spruss, T., Pfeifer, A., Fassler, R., and Bosserhoff, A.K. (2009). Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J. Exp. Med. 206, 221-232.
Rutberg, S.E., Goldstein, I.M., Yang, Y.M., Stackpole, C.W., and Ronai, Z. (1994). Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones. Mol. Carcinog. 10, 82-87.
Zenz, R., Scheuch, H., Martin, P., Frank, C., Eferl, R., Kenner, L., Sibilia, M., and Wagner, E.F. (2003). c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879-889.
Meier, F., Caroli, U., Satyamoorthy, K. et al. (2003). Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma. Exp. Dermatol. 12, 296-306.
Pla, P., Moore, R., Morali, O.G., Grille, S., Martinozzi, S., Delmas, V., and Larue, L. (2001). Cadherins in neural crest cell development and transformation. J. Cell. Physiol. 189, 121-132.
Andersen, H., Mejlvang, J., Mahmood, S., Gromova, I., Gromov, P., Lukanidin, E., Kriajevska, M., Mellon, J.K., and Tulchinsky, E. (2005). Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol. Cell. Biol. 25, 9138-9150.
Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447-460.
Sanders, D.S., Blessing, K., Hassan, G.A., Bruton, R., Marsden, J.R., and Jankowski, J. (1999). Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol. Pathol. 52, 151-157.
Bowden, G.T., Schneider, B., Domann, R., and Kulesz-Martin, M. (1994). Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res. 54, 1882s-1885s.
Cruz-Munoz, W., Man, S., Xu, P., and Kerbel, R.S. (2008). Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res. 68, 4500-4505.
Devary, Y., Gottlieb, R.A., Smeal, T., and Karin, M. (1992). The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71, 1081-1091.
Dhar, A., Young, M.R., and Colburn, N.H. (2002). The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 234-235, 185-193.
Jankowski, J.A., Bruton, R., Shepherd, N., and Sanders, D.S. (1997). Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol. Pathol. 50, 289-290.
Poser, I., Dominguez, D., de Herreros, A.G., Varnai, A., Buettner, R., and Bosserhoff, A.K. (2001). Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J. Biol. Chem. 276, 24661-24666.
Hsu, M.Y., Wheelock, M.J., Johnson, K.R., and Herlyn, M. (1996). Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investig. Dermatol. Symp. Proc. 1, 188-194.
Jochum, W., Passegue, E., and Wagner, E.F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.
Gupta, S., Campbell, D., Derijard, B., and Davis, R.J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
Kovary, K., and Bravo, R. (1991). The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11, 4466-4472.
Mils, V., Piette, J., Barette, C., Veyrune, J., Tesniere, A., Escot, C., Guilhou, J.J., and Basset-Seguin, N. (1997). The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 14, 1555-1561.
Devary, Y., Gottlieb, R.A., Lau, L.F., and Karin, M. (1991). Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11, 2804-2811.
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E.F., and Karin, M. (2000). The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 103, 897-907.
Jacob, K., Wach, F., Holzapfel, U., Hein, R., Lengyel, E., Buettner, R., and Bosserhoff, A.K. (1998). In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res. 8, 211-219.
Dong, Z., Birrer, M.J., Watts, R.G., Matrisian, L.M., and Colburn, N.H. (1994). Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA 91, 609-613.
Kolomeichuk, S.N., Terrano, D.T., Lyle, C.S., Sabapathy, K., and Chambers, T.C. (2008). Distinct signaling pathways of microtubule inhibitors - vinblastine and Taxol induce JNK-dependent cell death but through
2001; 189
1995; 72
1991; 354
1991; 353
1991; 11
2004; 23
1994; 371
2004; 3
1995; 130
1988; 106
1998; 392
2005; 25
2003; 12
2007; 29
1990; 87
1997; 50
1997; 14
2006; 25
2003; 2
1992; 116
2003; 3
2003; 4
2008; 68
2000; 60
1996; 1
1999; 52
1988; 85
2009; 206
2008; 275
1989; 337
2009; 20
2000; 26
1995; 14
2000; 20
2000; 156
2007; 11
1996; 15
1992; 71
1995; 270
2001; 20
2001; 276
1988; 3
2005; 19
1995; 81
1989; 244
2004; 19
2000; 103
2004; 14
1997; 38
2002; 234–235
1995; 267
1994; 91
1994; 2
1994; 54
1994; 10
1998; 186
1998; 8
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_9_1
e_1_2_8_43_1
Wenke A.K. (e_1_2_8_63_1) 2007; 29
e_1_2_8_45_1
Poser I. (e_1_2_8_48_1) 2004; 19
e_1_2_8_62_1
e_1_2_8_41_1
e_1_2_8_17_1
Hsu M.Y. (e_1_2_8_22_1) 1996; 1
e_1_2_8_19_1
Sommers C.L. (e_1_2_8_60_1) 1994; 54
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_57_1
Halaban R. (e_1_2_8_20_1) 1988; 3
e_1_2_8_32_1
e_1_2_8_55_1
Xiao L. (e_1_2_8_64_1) 2000; 60
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
Bowden G.T. (e_1_2_8_7_1) 1994; 54
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_65_1
e_1_2_8_40_1
e_1_2_8_61_1
e_1_2_8_18_1
e_1_2_8_39_1
Rimm D.L. (e_1_2_8_52_1) 1995; 72
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_58_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_56_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_50_1
References_xml – volume: 23
  start-page: 6115
  year: 2004
  end-page: 6124
  article-title: Functional role of MIA in melanocytes and early development of melanoma
  publication-title: Oncogene
– volume: 11
  start-page: 4466
  year: 1991
  end-page: 4472
  article-title: The jun and fos protein families are both required for cell cycle progression in fibroblasts
  publication-title: Mol. Cell. Biol.
– volume: 244
  start-page: 566
  year: 1989
  end-page: 569
  article-title: AP1/jun function is differentially induced in promotion‐sensitive and resistant JB6 cells
  publication-title: Science
– volume: 189
  start-page: 121
  year: 2001
  end-page: 132
  article-title: Cadherins in neural crest cell development and transformation
  publication-title: J. Cell. Physiol.
– volume: 19
  start-page: 173
  year: 2004
  end-page: 188
  article-title: Transcription factors involved in development and progression of malignant melanoma
  publication-title: Histol. Histopathol.
– volume: 25
  start-page: 9138
  year: 2005
  end-page: 9150
  article-title: Immediate and delayed effects of E‐cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells
  publication-title: Mol. Cell. Biol.
– volume: 26
  start-page: 16
  year: 2000
  end-page: 17
  article-title: Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
  publication-title: Nat. Genet.
– volume: 14
  start-page: 1555
  year: 1997
  end-page: 1561
  article-title: The proto‐oncogene c‐fos increases the sensitivity of keratinocytes to apoptosis
  publication-title: Oncogene
– volume: 116
  start-page: 989
  year: 1992
  end-page: 996
  article-title: Molecular organization of the uvomorulin‐catenin complex
  publication-title: J. Cell Biol.
– volume: 68
  start-page: 4500
  year: 2008
  end-page: 4505
  article-title: Development of a preclinical model of spontaneous human melanoma central nervous system metastasis
  publication-title: Cancer Res.
– volume: 12
  start-page: 296
  year: 2003
  end-page: 306
  article-title: Fibroblast growth factor‐2 but not Mel‐CAM and/or beta3 integrin promotes progression of melanocytes to melanoma
  publication-title: Exp. Dermatol.
– volume: 20
  start-page: 2390
  year: 2001
  end-page: 2400
  article-title: AP‐1 in cell proliferation and survival
  publication-title: Oncogene
– volume: 38
  start-page: 343
  year: 1997
  end-page: 352
  article-title: Roles of E‐ and P‐cadherin in the human skin
  publication-title: Microsc. Res. Tech.
– volume: 29
  start-page: 373
  year: 2007
  end-page: 386
  article-title: Expression of integrin alpha10 is induced in malignant melanoma
  publication-title: Cell. Oncol.
– volume: 14
  start-page: 29
  year: 2004
  end-page: 41
  article-title: The small GTP‐binding protein RhoA regulates c‐jun by a ROCK‐JNK signaling axis
  publication-title: Mol. Cell
– volume: 276
  start-page: 24661
  year: 2001
  end-page: 24666
  article-title: Loss of E‐cadherin expression in melanoma cells involves up‐regulation of the transcriptional repressor Snail
  publication-title: J. Biol. Chem.
– volume: 234–235
  start-page: 185
  year: 2002
  end-page: 193
  article-title: The role of AP‐1, NF‐kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive
  publication-title: Mol. Cell. Biochem.
– volume: 337
  start-page: 661
  year: 1989
  end-page: 663
  article-title: Prolonged activation of jun and collagenase genes by tumour necrosis factor‐alpha
  publication-title: Nature
– volume: 371
  start-page: 171
  year: 1994
  end-page: 175
  article-title: c‐Fos transcriptional activity stimulated by H‐Ras‐activated protein kinase distinct from JNK and ERK
  publication-title: Nature
– volume: 2
  start-page: 199
  year: 2003
  end-page: 201
  article-title: Role of JNK in tumor development
  publication-title: Cell Cycle
– volume: 106
  start-page: 761
  year: 1988
  end-page: 771
  article-title: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
  publication-title: J. Cell Biol.
– volume: 353
  start-page: 670
  year: 1991
  end-page: 674
  article-title: Phosphorylation of c‐jun mediated by MAP kinases
  publication-title: Nature
– volume: 275
  start-page: 1889
  year: 2008
  end-page: 1899
  article-title: Distinct signaling pathways of microtubule inhibitors – vinblastine and Taxol induce JNK‐dependent cell death but through AP‐1‐dependent and AP‐1‐independent mechanisms, respectively
  publication-title: FEBS J.
– volume: 156
  start-page: 1515
  year: 2000
  end-page: 1525
  article-title: E‐cadherin expression in melanoma cells restores keratinocyte‐mediated growth control and down‐regulates expression of invasion‐related adhesion receptors
  publication-title: Am. J. Pathol.
– volume: 60
  start-page: 400
  year: 2000
  end-page: 408
  article-title: A dominant role for the c‐Jun NH2‐terminal kinase in oncogenic ras‐induced morphologic transformation of human lung carcinoma cells
  publication-title: Cancer Res.
– volume: 20
  start-page: 575
  year: 2000
  end-page: 582
  article-title: c‐Jun‐dependent CD95‐L expression is a rate‐limiting step in the induction of apoptosis by alkylating agents
  publication-title: Mol. Cell. Biol.
– volume: 72
  start-page: 506
  year: 1995
  end-page: 512
  article-title: Reduced alpha‐catenin and E‐cadherin expression in breast cancer
  publication-title: Lab. Invest.
– volume: 103
  start-page: 897
  year: 2000
  end-page: 907
  article-title: The mammalian UV response: c‐Jun induction is required for exit from p53‐imposed growth arrest
  publication-title: Cell
– volume: 11
  start-page: 447
  year: 2007
  end-page: 460
  article-title: Rewired ERK‐JNK signaling pathways in melanoma
  publication-title: Cancer Cell
– volume: 52
  start-page: 151
  year: 1999
  end-page: 157
  article-title: Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours
  publication-title: Mol. Pathol.
– volume: 206
  start-page: 221
  year: 2009
  end-page: 232
  article-title: Down‐regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
  publication-title: J. Exp. Med.
– volume: 68
  start-page: 3645
  year: 2008
  end-page: 3654
  article-title: Loss of E‐cadherin promotes metastasis via multiple downstream transcriptional pathways
  publication-title: Cancer Res.
– volume: 267
  start-page: 389
  year: 1995
  end-page: 393
  article-title: Transcription factor ATF2 regulation by the JNK signal transduction pathway
  publication-title: Science
– volume: 19
  start-page: 309
  year: 2005
  end-page: 320
  article-title: RACK1 mediates activation of JNK by protein kinase C
  publication-title: Mol. Cell
– volume: 91
  start-page: 609
  year: 1994
  end-page: 613
  article-title: Blocking of tumor promoter‐induced AP‐1 activity inhibits induced transformation in JB6 mouse epidermal cells
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 14
  start-page: 6107
  year: 1995
  end-page: 6115
  article-title: E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
  publication-title: EMBO J.
– volume: 23
  start-page: 8509
  year: 2004
  end-page: 8519
  article-title: Loss of E‐cadherin leads to upregulation of NFkappaB activity in malignant melanoma
  publication-title: Oncogene
– volume: 20
  start-page: 2401
  year: 2001
  end-page: 2412
  article-title: AP‐1 in mouse development and tumorigenesis
  publication-title: Oncogene
– volume: 186
  start-page: 350
  year: 1998
  end-page: 355
  article-title: E‐cadherin/catenin complex in benign and malignant melanocytic lesions
  publication-title: J. Pathol.
– volume: 50
  start-page: 289
  year: 1997
  end-page: 290
  article-title: Cadherin and catenin biology represent a global mechanism for epithelial cancer progression
  publication-title: Mol. Pathol.
– volume: 10
  start-page: 82
  year: 1994
  end-page: 87
  article-title: Expression and transcriptional activity of AP‐1, CRE, and URE binding proteins in B16 mouse melanoma subclones
  publication-title: Mol. Carcinog.
– volume: 270
  start-page: 16483
  year: 1995
  end-page: 16486
  article-title: The regulation of AP‐1 activity by mitogen‐activated protein kinases
  publication-title: J. Biol. Chem.
– volume: 3
  start-page: 859
  year: 2003
  end-page: 868
  article-title: AP‐1: a double‐edged sword in tumorigenesis
  publication-title: Nat. Rev. Cancer
– volume: 8
  start-page: 211
  year: 1998
  end-page: 219
  article-title: In vitro modulation of human melanoma cell invasion and proliferation by all‐trans‐retinoic acid
  publication-title: Melanoma Res.
– volume: 25
  start-page: 248
  year: 2006
  end-page: 259
  article-title: Influence of the cytoplasmic domain of E‐cadherin on endogenous N‐cadherin expression in malignant melanoma
  publication-title: Oncogene
– volume: 2
  start-page: 319
  year: 1994
  end-page: 327
  article-title: A short core region of E‐cadherin is essential for catenin binding and is highly phosphorylated
  publication-title: Cell Adhes. Commun.
– volume: 11
  start-page: 2804
  year: 1991
  end-page: 2811
  article-title: Rapid and preferential activation of the c‐jun gene during the mammalian UV response
  publication-title: Mol. Cell. Biol.
– volume: 25
  start-page: 665
  year: 2006
  end-page: 676
  article-title: The cytoskeletal network controls c‐Jun translation in a UTR‐dependent manner
  publication-title: Oncogene
– volume: 20
  start-page: 3616
  year: 2000
  end-page: 3625
  article-title: UV‐Induced stabilization of c‐fos and other short‐lived mRNAs
  publication-title: Mol. Cell. Biol.
– volume: 1
  start-page: 188
  year: 1996
  end-page: 194
  article-title: Shifts in cadherin profiles between human normal melanocytes and melanomas
  publication-title: J. Investig. Dermatol. Symp. Proc.
– volume: 20
  start-page: 2121
  year: 2009
  end-page: 9
  article-title: Loss of E‐cadherin mediated cell–cell contacts activates a novel mechanism for upregulation of the proto‐oncogene c‐Jun
  publication-title: Mol. Biol. Cell.
– volume: 85
  start-page: 8464
  year: 1988
  end-page: 8467
  article-title: Induction of protooncogene c‐jun by serum growth factors
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 54
  start-page: 3544
  year: 1994
  end-page: 3552
  article-title: Alterations in beta‐catenin phosphorylation and plakoglobin expression in human breast cancer cells
  publication-title: Cancer Res.
– volume: 54
  start-page: 1882s
  year: 1994
  end-page: 1885s
  article-title: Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis
  publication-title: Cancer Res.
– volume: 3
  start-page: 177
  year: 1988
  end-page: 186
  article-title: bFGF as an autocrine growth factor for human melanomas
  publication-title: Oncogene Res.
– volume: 15
  start-page: 507
  year: 1996
  end-page: 525
  article-title: Role of intermediate filaments in migration, invasion and metastasis
  publication-title: Cancer Metastasis Rev.
– volume: 81
  start-page: 53
  year: 1995
  end-page: 62
  article-title: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
  publication-title: Cell
– volume: 3
  start-page: 111
  year: 2004
  end-page: 113
  article-title: Deregulated repression of c‐Jun provides a potential link to its role in tumorigenesis
  publication-title: Cell Cycle
– volume: 71
  start-page: 1081
  year: 1992
  end-page: 1091
  article-title: The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases
  publication-title: Cell
– volume: 392
  start-page: 402
  year: 1998
  end-page: 405
  article-title: E‐cadherin germline mutations in familial gastric cancer
  publication-title: Nature
– volume: 4
  start-page: 879
  year: 2003
  end-page: 889
  article-title: c‐Jun regulates eyelid closure and skin tumor development through EGFR signaling
  publication-title: Dev. Cell
– volume: 87
  start-page: 4246
  year: 1990
  end-page: 4250
  article-title: Uvomorulin‐catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 354
  start-page: 494
  year: 1991
  end-page: 496
  article-title: Oncogenic and transcriptional cooperation with Ha‐Ras requires phosphorylation of c‐Jun on serines 63 and 73
  publication-title: Nature
– volume: 130
  start-page: 67
  year: 1995
  end-page: 77
  article-title: Interaction of alpha‐actinin with the cadherin/catenin cell–cell adhesion complex via alpha‐catenin
  publication-title: J. Cell Biol.
– ident: e_1_2_8_17_1
  doi: 10.1038/79120
– ident: e_1_2_8_36_1
  doi: 10.1016/j.molcel.2005.06.025
– volume: 54
  start-page: 3544
  year: 1994
  ident: e_1_2_8_60_1
  article-title: Alterations in beta‐catenin phosphorylation and plakoglobin expression in human breast cancer cells
  publication-title: Cancer Res.
  contributor:
    fullname: Sommers C.L.
– ident: e_1_2_8_32_1
  doi: 10.1111/j.1742-4658.2008.06349.x
– ident: e_1_2_8_24_1
  doi: 10.1097/00008390-199806000-00003
– ident: e_1_2_8_46_1
  doi: 10.1002/jcp.10008
– ident: e_1_2_8_11_1
  doi: 10.1128/MCB.11.5.2804
– ident: e_1_2_8_13_1
  doi: 10.1023/A:1015948505117
– ident: e_1_2_8_41_1
  doi: 10.1038/sj.onc.1200991
– ident: e_1_2_8_57_1
  doi: 10.1016/S0092-8674(00)00193-8
– ident: e_1_2_8_21_1
  doi: 10.1007/BF00054016
– ident: e_1_2_8_45_1
  doi: 10.1073/pnas.87.11.4246
– volume: 54
  start-page: 1882s
  year: 1994
  ident: e_1_2_8_7_1
  article-title: Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis
  publication-title: Cancer Res.
  contributor:
    fullname: Bowden G.T.
– ident: e_1_2_8_37_1
  doi: 10.1016/j.ccr.2007.03.009
– ident: e_1_2_8_25_1
  doi: 10.1136/mp.50.6.289
– ident: e_1_2_8_50_1
  doi: 10.1038/sj.onc.1207797
– ident: e_1_2_8_42_1
  doi: 10.1016/0092-8674(95)90370-4
– ident: e_1_2_8_15_1
  doi: 10.1038/nrc1209
– volume: 60
  start-page: 400
  year: 2000
  ident: e_1_2_8_64_1
  article-title: A dominant role for the c‐Jun NH2‐terminal kinase in oncogenic ras‐induced morphologic transformation of human lung carcinoma cells
  publication-title: Cancer Res.
  contributor:
    fullname: Xiao L.
– ident: e_1_2_8_38_1
  doi: 10.1016/S1097-2765(04)00153-4
– ident: e_1_2_8_16_1
  doi: 10.1002/(SICI)1097-0029(19970815)38:4<343::AID-JEMT2>3.0.CO;2-K
– volume: 19
  start-page: 173
  year: 2004
  ident: e_1_2_8_48_1
  article-title: Transcription factors involved in development and progression of malignant melanoma
  publication-title: Histol. Histopathol.
  contributor:
    fullname: Poser I.
– volume: 72
  start-page: 506
  year: 1995
  ident: e_1_2_8_52_1
  article-title: Reduced alpha‐catenin and E‐cadherin expression in breast cancer
  publication-title: Lab. Invest.
  contributor:
    fullname: Rimm D.L.
– ident: e_1_2_8_10_1
  doi: 10.1038/371171a0
– ident: e_1_2_8_4_1
  doi: 10.1002/j.1460-2075.1995.tb00301.x
– ident: e_1_2_8_12_1
  doi: 10.1016/S0092-8674(05)80058-3
– ident: e_1_2_8_14_1
  doi: 10.1073/pnas.91.2.609
– ident: e_1_2_8_62_1
  doi: 10.4161/cc.3.2.648
– ident: e_1_2_8_30_1
  doi: 10.1083/jcb.130.1.67
– ident: e_1_2_8_53_1
  doi: 10.1002/mc.2940100205
– ident: e_1_2_8_5_1
  doi: 10.1128/MCB.20.10.3616-3625.2000
– volume: 3
  start-page: 177
  year: 1988
  ident: e_1_2_8_20_1
  article-title: bFGF as an autocrine growth factor for human melanomas
  publication-title: Oncogene Res.
  contributor:
    fullname: Halaban R.
– volume: 1
  start-page: 188
  year: 1996
  ident: e_1_2_8_22_1
  article-title: Shifts in cadherin profiles between human normal melanocytes and melanomas
  publication-title: J. Investig. Dermatol. Symp. Proc.
  contributor:
    fullname: Hsu M.Y.
– ident: e_1_2_8_44_1
  doi: 10.1083/jcb.116.4.989
– ident: e_1_2_8_47_1
  doi: 10.1038/sj.onc.1209114
– ident: e_1_2_8_33_1
  doi: 10.1128/MCB.11.9.4466
– ident: e_1_2_8_29_1
  doi: 10.1091/mbc.E08-12-1196
– ident: e_1_2_8_34_1
  doi: 10.1038/sj.onc.1209054
– ident: e_1_2_8_39_1
  doi: 10.1084/jem.20082044
– ident: e_1_2_8_59_1
  doi: 10.1038/354494a0
– ident: e_1_2_8_35_1
  doi: 10.1038/sj.onc.1207831
– ident: e_1_2_8_56_1
  doi: 10.1038/sj.onc.1204383
– ident: e_1_2_8_6_1
  doi: 10.1083/jcb.106.3.761
– ident: e_1_2_8_27_1
  doi: 10.1074/jbc.270.28.16483
– ident: e_1_2_8_61_1
  doi: 10.3109/15419069409014207
– ident: e_1_2_8_54_1
  doi: 10.1073/pnas.85.22.8464
– ident: e_1_2_8_28_1
  doi: 10.4161/cc.2.3.388
– ident: e_1_2_8_31_1
  doi: 10.1128/MCB.20.2.575-582.2000
– ident: e_1_2_8_3_1
  doi: 10.1126/science.2541502
– ident: e_1_2_8_43_1
  doi: 10.1158/0008-5472.CAN-07-2938
– ident: e_1_2_8_58_1
  doi: 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K
– ident: e_1_2_8_23_1
  doi: 10.1016/S0002-9440(10)65023-7
– ident: e_1_2_8_18_1
  doi: 10.1038/32918
– volume: 29
  start-page: 373
  year: 2007
  ident: e_1_2_8_63_1
  article-title: Expression of integrin alpha10 is induced in malignant melanoma
  publication-title: Cell. Oncol.
  contributor:
    fullname: Wenke A.K.
– ident: e_1_2_8_19_1
  doi: 10.1126/science.7824938
– ident: e_1_2_8_40_1
  doi: 10.1034/j.1600-0625.2003.120310.x
– ident: e_1_2_8_55_1
  doi: 10.1136/mp.52.3.151
– ident: e_1_2_8_65_1
  doi: 10.1016/S1534-5807(03)00161-8
– ident: e_1_2_8_49_1
  doi: 10.1074/jbc.M011224200
– ident: e_1_2_8_9_1
  doi: 10.1158/0008-5472.CAN-08-0041
– ident: e_1_2_8_26_1
  doi: 10.1038/sj.onc.1204389
– ident: e_1_2_8_51_1
  doi: 10.1038/353670a0
– ident: e_1_2_8_2_1
  doi: 10.1128/MCB.25.20.9138-9150.2005
– ident: e_1_2_8_8_1
  doi: 10.1038/337661a0
SSID ssj0060593
Score 2.1493537
Snippet Summary A central event in the development of malignant melanoma is the loss of the tumor‐suppressor protein E‐cadherin. Here, we report that this loss is...
A central event in the development of malignant melanoma is the loss of the tumor-suppressor protein E-cadherin. Here, we report that this loss is linked to...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 148
SubjectTerms c-Jun
c-Jun protein
Cadherins - metabolism
Cell Adhesion
Cell Line, Tumor
Cytoskeleton
Cytoskeleton - metabolism
Data processing
E-Cadherin
Gene Expression Regulation, Neoplastic
Humans
malignant melanoma
Melanocytes
Melanoma
Melanoma - enzymology
Melanoma - genetics
Melanoma - pathology
Mitogen-Activated Protein Kinases - metabolism
Pigments
Post-transcription
post-transcriptional regulation
Proto-Oncogene Proteins c-jun - genetics
Proto-Oncogene Proteins c-jun - metabolism
Proto-oncogenes
Signal transduction
Transcription
Transcription factors
Transcription, Genetic
Translation
Tumorigenesis
Title Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma
URI https://api.istex.fr/ark:/67375/WNG-VF7RSCK8-Q/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1755-148X.2010.00787.x
https://www.ncbi.nlm.nih.gov/pubmed/20977688
https://search.proquest.com/docview/1028075503
https://search.proquest.com/docview/840350313
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zi9RAEC50RfDF-4gXLYhvkc7Rnc6jjDPKisu667H40vQJqzsZmQPWN3-Cv9FfYlVnMjiygohvCanOUefXneoqgMdB8rL11DRDRZ7XsfK5KaLJpW24K2JJkqeli8Nm70g9H1OZnN1hL0xfH2Kz4EaWkfw1Gbixi20jb4TIEc4fDRlaqHxPCU_ipCHt5qj2B6cseV9_dz2kKX5L6jnrRluR6gIx_fQsGLqNalNYmlz5nx90FS6vwSl71mvTNTgXuutw8eMsLb3fgE_U2ffHt-9Lim-Dt0H6ed_PHk_YOvP9JHhmv7IxEjvj0xZDdrxgx9OE9rslQ6jMHF7dXXWMtlZQBwuGRNNwYrrZ1NyEd5Px29HLfN2rIXcEaTDQIZaLdayLaD2CjKpyEZ2tkUqEtrBl5L71kUdXei5D5YUKynDl2ljXjZG8ugU73awLd4BZG_FctpYLV7vatlFYGZRwiJaMqEIGxSAX_aUvyaF_mcogDzXxUBMPdeKhPs3gSRLgZoCZf6aUtkboD3sv9PtJc3A4eqX0mwweDRLWaGj098R0YbZaaEJiiK8ErzJgf6DB2XIlqBpmBrd77dg8sOSItKVSGcikBH_96np_9PoAj-7-68B7cKlfCKccnPuws5yvwgM4v_Crh8lGfgIuFBGg
link.rule.ids 315,782,786,1408,27935,27936,46066,46490
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9QwELagFYIXbmg4jYR4C3LiI84jWnYpbLsqbYGqL5bjQyrtZtEeUnnjJ_Ab-SXMJJsVi4qEEG-JMs4xlz9PxjOEPA-K5aXHphk6slRE7lObRZuqqmAuizlKHkMXB8XoSL_uY5mcYbcXpq0PsQq4oWU0_hoNHAPS61ZeSJkCnj_qUrRA-14CoNwUSpTYx4Hzvc4tK9ZW4F2OKbLf0nouutPaXLWJbD-_CIiu49pmYhrc-K-fdJNcX-JT-qpVqFvkUqhvkyvHkyb6fod8xua-P759n-MU1zkcoJ-2Le3hhC6T38-Cp9VX2gdiZ32zy5CezOjJuAH89ZwCWqYOrr5b1BR3V2ATCwpE43Bm68nY3iUfBv3D3na6bNeQOkQ1MNcBnIsiiixWHnAG5y6Cv7VKy1BmVR6ZL31k0eWeqcC91EFbpl0ZhSisYvwe2agnddgitKoinKuyYtIJJ6oyykoFLR0AJit5SEjWCcZ8aatymF9WM8BDgzw0yEPT8NCcJ-RFI8HVADs9xay2QppPozfm46DYP-gNtXmfkGediA3YGv5AsXWYLGYGwRhALMl4QugfaGDBzCUWxEzI_VY9Vg_MGYBtpXVCVKMFf_3qZq-3uw9HD_514FNydftwd8fsvB0NH5JrbVwcU3IekY35dBEek8szv3jSGMxPXl8VwQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9QwEB5BKxAvlJtQDiMh3oKcw47ziLa7QAurpeWoeLEcH1Khm632kMobP6G_sb-EmWSzYlGREOItUcY5Zjwzn505AJ55ydPSUdMMFXich8zFJgkmllXBbRJSkjxtXRwUw0O106cyObtdLkxbH2K14Uaa0dhrUvATF9aVvBAiRjh_2EVo4eR7gXhyMydUTukc2aizypK3BXiXY4rkt6iei-605qo2ieunF-HQdVjb-KXB1v_8ohtwfYlO2ct2Ot2ES76-BVe-TJq999vwlVr7nv84m5OD68wN0k_bhvZ4wpah78feseo76yOxNa7JMWRHM3Y0buB-PWeIlZnFq7uLmlFuBbWwYEg09semnozNHfg46H_ovY6XzRpiS5gGPR2CuZCHPAmVQ5SRZTagtTVSCV8mVRq4K13gwaaOS585obwyXNky5HlhJM_uwkY9qf19YFUV8FyWFRc2t3lVBlFJr4RFuGRE5iNIOrnok7Ymh_5lLYM81MRDTTzUDQ_1aQTPGwGuBpjpN4ppK4T-PHylPw2K_YPentLvI3jaSVijptHvE1P7yWKmCYohwBI8i4D9gQaXy5mgcpgR3Gtnx-qBKUeoLZWKQDaT4K9fXY967_bx6MG_DnwCV0c7A_32zXBvG661m-IUj_MQNubThX8El2du8bhRl58AdxRw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post%E2%80%90transcriptional+regulation+controlled+by+E%E2%80%90cadherin+is+important+for+c%E2%80%90Jun+activity+in+melanoma&rft.jtitle=Pigment+cell+and+melanoma+research&rft.au=Spangler%2C+B.&rft.au=Vardimon%2C+L.&rft.au=Bosserhoff%2C+A.+K.&rft.au=Kuphal%2C+S.&rft.date=2011-02-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1755-1471&rft.eissn=1755-148X&rft.volume=24&rft.issue=1&rft.spage=148&rft.epage=164&rft_id=info:doi/10.1111%2Fj.1755-148X.2010.00787.x&rft.externalDBID=10.1111%252Fj.1755-148X.2010.00787.x&rft.externalDocID=PCMR787
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-1471&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-1471&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-1471&client=summon